Fabry Disease Screening in ESRD Patients in West of France
Completed
- Conditions
- ESRD
- Interventions
- Other: Dried blood spot test
- Registration Number
- NCT02719249
- Lead Sponsor
- Rennes University Hospital
- Brief Summary
Screening of Fabry disease in end-stage renal disease (ESRD) patients on dialysis or transplant in west of France.
- Detailed Description
Detection of Fabry disease is done by dried blood spot test, in dialyzed and transplanted men, who reached ESRD for vascular or unknown disease and were not previously screened.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 500
Inclusion Criteria
- Men less than 70 years old
- ESRD treated by dialysis or kidney graft in one of the 4 following regions : Bretagne, Centre, Pays de la Loire and Poitou-Charentes
- For unknown nephropathy OR vascular nephropathy and/or diabetic nephropathy unproved by biopsy
- Agreeing freely to participate in the study
Exclusion Criteria
- Men less than 18 years old
- Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Men with ESRD on dialysis or transplant Dried blood spot test -
- Primary Outcome Measures
Name Time Method To detect Fabry disease by dried blood spot test, in dialyzed and transplanted men, who reached ESRD for vascular or unknown disease and were not previously screened 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
CHU de Rennes
🇫🇷Rennes, France